Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
EQS-News

LifeQuest World Corp. Reports First Quarter Fiscal 2027 Results as a Combined Company: Revenue of $885,400, Net Income of $24,249 and Total Assets of $2.1 Million 02.11.2026, 14:30 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
LifeQuest World 0,010908 USD -12,68 % Nasdaq OTC
Kostenlose Aktienchance per SMS Ausgewählte Trading-Einschätzungen aufs Handy.

EQS-News: LifeQuest World Corp. / Key word(s): Financial
LifeQuest World Corp. Reports First Quarter Fiscal 2027 Results as a Combined Company: Revenue of $885,400, Net Income of $24,249 and Total Assets of $2.1 Million

02.11.2026 / 14:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


RIDGEFIELD PARK, NJ - November 2, 2026 (NEWMEDIAWIRE) - LifeQuest World Corp. (OTCID: LQWC) (“LifeQuest” or the “Company”), a diversified environmental solutions company focused on decentralized wastewater treatment, solid waste compaction and recycling equipment, and organic waste processing, today announced that it has filed its Quarterly Report and unaudited consolidated financial statements for the fiscal first quarter ended August 31, 2026 with OTC Markets. The filing is the Company’s first formal report as a combined company following its June 12, 2026 acquisition of Compaction and Recycling Equipment, Inc. (“CARE”) and Columbia Financial Services, Inc. (“CFSI”).

The quarter marks a fundamental change in the scale of LifeQuest’s business. With CARE and CFSI now consolidated alongside BioPipe Global Corp., the Company reported significant revenue, positive net income and a substantially strengthened balance sheet. Year-over-year comparisons primarily reflect the addition of the acquired operations. In connection with the integration, LifeQuest has relocated its headquarters from Ridgefield Park, New Jersey to Clackamas, Oregon.

First quarterly filing to include newly acquired CARE and CFSI; stockholders’ equity turns positive at $519,104, working capital of $397,302, and approximately $935,000 in deferred revenue**

First Quarter Fiscal 2027 Highlights

Income Statement

  • Revenue of $885,400, compared with no revenue in the same quarter of the prior year.
  • Gross profit of $568,935, representing a gross margin of approximately 64%.
  • Pretax income of $24,249, compared with a net loss of $(56,300) in the prior-year quarter, a year-over-year improvement of $80,549.

Balance Sheet

  • Total assets of $2,125,492.
  • Cash and cash equivalents of $548,200, up from $187,320 at May 31, 2026 and $110,846 at August 31, 2025.
  • Stockholders’ equity of $519,104, compared with a stockholders’ deficit of $(158,854) at fiscal year-end May 31, 2026.
  • Positive working capital of $397,302 and a current ratio of 1.25x, compared with negative working capital of $(65,933) a year earlier.
  • **Unearned income (deferred revenue) of $935,226, representing amounts billed or received in advance that the Company expects to recognize as revenue in future periods as performance obligations are satisfied. For Biopipe Global, revenue is recognized once plant is handed over even though progress payment may have been received.
  • Modest debt load: interest-bearing obligations of $100,000 in principal, consisting of an $85,000 promissory note and a $15,000 convertible note, with no long-term debt on the balance sheet.
  • No cash paid at closing for the CARE and CFSI acquisition, which was completed for Series B Preferred Stock and an $85,000 promissory note.

Selected Financial Data

(Unaudited, US$)

Q1 FY2027

Comparative

Statement of Operations - three months ended August 31

 

2026

2025

Revenue

$885,400

$0

Gross profit

$568,935

$1,467

Gross margin

64.3%

n/m

Operating income (loss)

$25,816

$(56,822)

Balance Sheet

 

Aug 31, 2026

Aug 31, 2025

Cash and cash equivalents

$548,200

$110,846

Accounts receivable

$679,851

$17,355

Total current assets

$2,003,690

$383,213

Total assets

$2,125,492

$516,160

Total current liabilities

$1,606,388

$449,146

Working capital

$397,302

$(65,933)

Current ratio

1.25x

0.85x

Unearned income (deferred revenue)

$935,226

$248,828

Total stockholders' equity

$519,104

$67,014

Source: Company Quarterly Report for the period ended August 31, 2026. Financial statements are unaudited and were not subject to an audit, review, or compilation. Operating income equals gross profit less operating expenses. Working capital equals total current assets less total current liabilities. n/m = not meaningful.

Management Commentary

“This filing is the first look at LifeQuest as the company we set out to build,” said Max Khan, President and Chief Executive Officer of LifeQuest. “In a single quarter we moved from a development-stage wastewater technology company to a profitable environmental services platform with nearly $900,000 in quarterly revenue, more than $2.1 million in assets and positive stockholders’ equity. CARE and CFSI give us a recurring revenue foundation in the Pacific Northwest, while BioPipe continues to win orders internationally, including two recent containerized sewage treatment plants for labor camps in the United Arab Emirates. Our priority now is completing a PCAOB audit and SEC registration so that investors can value LifeQuest on a fully reported basis.”

Strategic Roadmap

LifeQuest is pursuing a defined path toward full SEC reporting status and a higher-tier market listing. The Company intends to complete a PCAOB-standard audit, file a registration statement with the SEC (Form 10 or Form S-1), and apply for quotation on the OTCQB Venture Market.

About LifeQuest World Corp.

LifeQuest World Corp. (OTCID: LQWC) is a diversified environmental solutions company headquartered in Clackamas, Oregon, serving commercial, institutional, hospitality and government customers through three operating businesses:

BioPipe Global Corp. develops and deploys decentralized biological sewage and wastewater treatment systems in which treatment takes place entirely inside the pipe. BioPipe systems are chemical-free, produce zero sludge, are virtually silent and odor-free, and have low energy use and a small footprint. Approximately 52 BioPipe plants are installed across Europe, Africa, South Asia, Southeast Asia and the Middle East, serving hospitals, resorts, hotels, commercial and government buildings, labor camps, ports and homes. The Company’s Abrimix process, using a patented static in-line high-shear reactor, addresses industrial effluent treatment.

Compaction and Recycling Equipment, Inc. (CARE) provides waste compaction and recycling equipment to commercial customers, including sales, rental and service of compactors, trash chutes, balers and on-site food-waste biodigesters.

Columbia Financial Services, Inc. (CFSI) provides equipment rental and related financial services that support CARE’s customers, generating recurring revenue from a rental fleet of waste-handling equipment.

CARE and CFSI reported combined unaudited revenue of approximately $3.48 million for the year ended December 31, 2025.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect the Company’s current beliefs, expectations or intentions regarding future events and are not statements of historical fact. Words such as “will,” “will be,” “anticipate,” “predict,” “expect,” “intend,” “plan,” “believe,” “continue,” “future,” and similar expressions are intended to identify such forward-looking statements. Statements regarding the Company’s ability to integrate CARE and CFSI, sustain revenue or profitability, recognize revenue from deferred revenue or purchase orders, complete a PCAOB audit, file a registration statement with the SEC, apply for or obtain quotation on the OTCQB Venture Market, conduct a reverse stock split, re-domicile to Nevada, or raise capital are forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied, many of which are outside the control of the Company and are difficult to predict. The financial information in this release is unaudited and may change upon completion of the Company’s audit and business combination accounting. Additional factors can be found in the Company’s disclosure statements at www.otcmarkets.com. The forward-looking statements in this press release are based upon information available to the Company as of the date of this release, and the Company undertakes no obligation to update any forward-looking statement, except as required by applicable law or regulation.

Investor & Media Contact
LifeQuest World Corp.
12250 SE Capps Road
Clackamas, Oregon 97015
Tel: 646-201-5242
Email: info@lifequestcorp.com
Web: www.lifequestcorp.com    BioPipe: www.biopipe.co    CARE: www.waste-equipment.com

OTC Markets: OTCID: LQWC

 

View the original release on www.newmediawire.com


News Source: LifeQuest World Corp.


02.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: LifeQuest World Corp.
United States
ISIN: US53222D2018
EQS News ID: 2426670

 
End of News EQS News Service

2426670  02.11.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News

Gestern 22:48 Uhr • Artikel • dpa-AFX

Gestern 22:31 Uhr • Artikel • dpa-AFX

Gestern 22:21 Uhr • Artikel • dpa-AFX

Gestern 21:21 Uhr • Artikel • dpa-AFX

Gestern 21:14 Uhr • Artikel • dpa-AFX

Gestern 21:08 Uhr • Artikel • dpa-AFX

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer